Navigation Links
Linden Enters Anatomic Pathology Sector Through Investment in Strata Pathology Services, Inc.
Date:7/26/2011

CHICAGO, July 26, 2011 /PRNewswire/ -- Linden LLC, a Chicago-based healthcare private equity firm, today announced that it has made an investment in Strata Pathology Services, Inc., a leading independent anatomic pathology laboratory in New England.

Headquartered in Lexington, Massachusetts, Strata offers anatomic pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology and gynecology segments. Since 1984, the company has developed proprietary knowledge, expertise and strong client relationships, and has established itself as a thought leader in the dermatopathology space.  

Linden Operating Partner Richard Novak, a 30-year veteran of the laboratory industry who previously was the chief operating officer of Laboratory Corporation of America (NYSE: LH), will serve as chairman of Strata. "The anatomic pathology market is an exciting and fast-growing segment of the lab industry, and Strata's strong position in the New England market, clinical expertise and high-quality customer service position it well for future growth," commented Novak.

Strata currently serves clients in more than 40 states and has recently added a number of international customers. With Linden's leadership, Strata will look to enhance its robust historical growth through a broadening of its testing menu and a more expansive outreach program to bring Strata's best-in-class client service and clinical expertise to a significantly wider customer base.

Robin Kirby, M.D., co-founder and medical director of Strata, added: "We are excited about our partnership with Linden during this next chapter for Strata. The expertise and capital that they bring to the table will help us to continue to bring the highest level of care to our customers and to expand our offering to many more physicians in New England and nationally."

England & Company acted as
'/>"/>

SOURCE Linden LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta Presenters at Lung Cancer Conference
2. BioMed Realty Trust Enters Into New $750 Million Unsecured Revolving Credit Facility
3. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
4. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
5. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
6. Sequenom Enters Into New $30.0 Million Credit Facility
7. Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
8. Sigma® Life Science Joins AMDeCs Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers
9. TriLink Enters Into Distribution Agreement With TATAA Biocenter
10. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
11. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... and segments with highest potential revenues Do you ... updated report gives you revenue predictions for those ... For those therapies you find financial data, R&D ... analysis you get sales forecasts to 2024 at ...
(Date:9/30/2014)... 2014 Over the last decade, the ... rising R&D budgets and increased acceptance of new filtration ... and biotechnology industries are also catalyzing the growth of ... is expected to grow at a strong CAGR during ... be worth $2,532.6 million by 2019. The market is ...
(Date:9/30/2014)...  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("the Company" ... a Canadian Patent for Inhibition or Reversal of ... claims using thymosin beta 4, various fragments and ... purposes.  The patent will expire in 2021. ... ) RegeneRx is focused on ...
(Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
Breaking Biology Technology:Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
... Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned subsidiary of ... received tentative approval from the U.S. Food,and Drug ... and 40 mg (base). Nexium(R) (Esomeprazole) is the,second ... annual market sales of,$5.5 billion (IMS -- MAT: ...
... Feb. 7 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) ... Access, is scheduled to deliver a presentation about the ... on February 13, 2008 at,12:30 pm Eastern Time. The ... City at the Waldorf Astoria Hotel., The presentation ...
... 7 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; ... Chief Executive Officer, is scheduled to present at,the ... Bentsur will present an,overview of the Company including ... for the treatment of diabetic neuropathic,pain. Mr. Bentsur,s ...
Cached Biology Technology:Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules 2Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference 2XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference 2
(Date:9/30/2014)... WASHINGTON, D.C., September 30, 2014--Sea monkeys have captured the ... of their easily observable life cycle -- sold as ... and mate given little more than a tank of ... a shorter-term pattern: Like other zooplankton, brine shrimp vertically ... conditions, coming closer to the surface at night and ...
(Date:9/30/2014)... LA JOLLAJoseph Ecker, a Salk professor and Howard ... staff scientist, have been named recipients in the ... of Health (NIH) through the BRAIN (Brain Research ... in neuroscience. The grant, announced September 30, provides ... Salk scientists over three years. , The BRAIN ...
(Date:9/30/2014)... (PCE) in drinking water may increase the risk ... new study led by a Boston University School ... in the journal Environmental Health , compared ... 1,766 women in Cape Cod, Ma., where water ... early 1980s by the installation of vinyl-lined asbestos ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Salk scientists receive $3 million for BRAIN Initiative grant 2Contaminated water linked to pregnancy complications, BU study finds 2
... due to loss of blood flow to the spine returned ... of human spinal stem cells (hSSCs), researchers from the University ... study, led by Martin Marsala, M.D., UC San Diego professor ... of the journal Neuroscience, which is now online. , “We ...
... a heart healthy diet can reduce cardiovascular disease risks ... at macadamia nuts because they are not currently included ... tree nuts are recommended as part of a healthy ... in nutritional sciences. "Macadamia nuts have higher levels of ...
... sea ice is melting at a significantly faster rate ... a new study concludes. The research, by scientists at ... University of Colorado's National Snow and Ice Data Center ... more rapidly than estimated by any of the 18 ...
Cached Biology News:Human stem cell treatment restores motor function in paralyzed rats 2Human stem cell treatment restores motor function in paralyzed rats 3Hawaiian treasure, macadamia nuts good for the heart 2Arctic ice retreating more quickly than computer models project 2Arctic ice retreating more quickly than computer models project 3
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
Anti-Goat HRP-DAB Cell & Tissue Staining Kit...
CHIMAERIC HUMAN IgA2 ANTI NP...
... Zero Background/Kan Cloning Kit includes ... resistance for selection in E. ... positive selection to eliminate high ... of the reagents you need ...
Biology Products: